| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Mohamed El Fadili, Mohammed Er-Rajy, Hamada Imtara, Omar M Noman, Ramzi A Mothana, Sheaf Abdullah, Sara Zerougui, Menana Elhallaou. QSAR, ADME-Tox, molecular docking and molecular dynamics simulations of novel selective glycine transporter type 1 inhibitors with memory enhancing properties. Heliyon. vol 9. issue 2. 2023-03-03. PMID:36865465. |
molecular docking results indicated that the predicted inhibitors block glyt1, reacting specifically with phe319, phe325, tyr123, tyr 124, arg52, asp475, ala117, ala479, ile116 and ile483 amino acids of the dopamine transporter (dat) membrane protein. |
2023-03-03 |
2023-08-14 |
human |
| Sara Af Bjerkén, Jan Axelsson, Anne Larsson, Carolina Flygare, Jussi Remes, Sara Strandberg, Linda Eriksson, David Bäckström, Susanna Jakobson M. Reliability and validity of visual analysis of [18F]FE-PE2I PET/CT in early Parkinsonian disease. Nuclear medicine communications. 2023-03-02. PMID:36862448. |
[18f]fe-pe2i (fe-pe2i) is a new radiotracer for dopamine transporter (dat) imaging with pet. |
2023-03-02 |
2023-08-14 |
Not clear |
| Seongbeom Park, Young Hee Sung, Woo Ram Kim, Young Noh, Eung Yeop Ki. Correlation Between Neuromelanin-Sensitive MRI and Journal of clinical neurology (Seoul, Korea). vol 19. issue 2. 2023-02-28. PMID:36854333. |
correlation between neuromelanin-sensitive mri and the correlation between dopamine transporter (dat) imaging and neuromelanin-sensitive magnetic resonance imaging (nm-mri) in early-stage parkinson's disease (pd) has not yet been established. |
2023-02-28 |
2023-08-14 |
Not clear |
| Youssef Chahid, Zulfiqar H Sheikh, Max Mitropoulos, Jan Booi. A systematic review of the potential effects of medications and drugs of abuse on dopamine transporter imaging using [ European journal of nuclear medicine and molecular imaging. 2023-02-27. PMID:36847827. |
a systematic review of the potential effects of medications and drugs of abuse on dopamine transporter imaging using [ in routine practice, dopamine transporter (dat) imaging is frequently used as a diagnostic tool to support the diagnosis of parkinson's disease or dementia with lewy bodies. |
2023-02-27 |
2023-08-14 |
Not clear |
| Elena Contaldi, Luca Magistrelli, Alessia Furgiuele, Silvia Gallo, Cristoforo Com. Relationship between [ Journal of neurology. 2023-02-25. PMID:36840790. |
nonetheless, the exact relationship with dopamine transporter (dat) spect denervation patterns is currently unknown. |
2023-02-25 |
2023-08-14 |
Not clear |
| V S Kerstens, P Fazio, M Sundgren, J Brumberg, C Halldin, P Svenningsson, A Varron. Longitudinal DAT changes measured with [ NeuroImage. Clinical. vol 37. 2023-02-23. PMID:36822016. |
longitudinal dat changes measured with [ dopamine transporter (dat) pet provides higher resolution than dat spect and opportunity for integrated imaging with mri. |
2023-02-23 |
2023-08-14 |
Not clear |
| Ashley L Holloway, Michael D Schaid, Talia N Lerne. Chronically dysregulated corticosterone impairs dopaminergic transmission in the dorsomedial striatum by sex-divergent mechanisms. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology. 2023-02-22. PMID:36810463. |
in male but not female mice, cort treatment impaired the function of the dopamine transporter (dat) in dms. |
2023-02-22 |
2023-08-14 |
mouse |
| Maciej M Jankowski, Bogna M Ignatowska-Jankowska, Wojciech Glac, Marek Wiergowski, Paulina Kazmierska-Grebowska, Artur H Swiergie. Intravenous haloperidol and cocaine alter the distribution of T CD3 Clinical and experimental pharmacology & physiology. 2023-02-21. PMID:36802086. |
cocaine non-specifically increases dopamine transmission by blocking dopamine active transporter (dat) and evokes behavioral arousal, while haloperidol is a non-specific d2-like dopamine receptor antagonist with sedative effects. |
2023-02-21 |
2023-08-14 |
rat |
| Da Hee Jung, Hong Ju Lee, Young Whan Choi, Hwa Kyoung Shin, Byung Tae Cho. Sex-specific responses to juvenile stress on the dopaminergic system in an animal model of attention-deficit hyperactivity disorder. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie. vol 160. 2023-02-04. PMID:36738506. |
dopamine clearance factors involved in dopamine degradation and transport, especially catechol-o-methyltransferase (comt) and dopamine transporter (dat), showed sex-specific differences induced by juvenile stress in dopamine metabolite assays. |
2023-02-04 |
2023-08-14 |
rat |
| Chan Lee, Jung-Hee Jang, Gyu Hwan Par. α-Pinene Attenuates Methamphetamine-Induced Conditioned Place Preference in C57BL/6 Mice. Biomolecules & therapeutics. 2023-02-03. PMID:36733209. |
methamphetamine (meth) is a powerful neurotoxic psychostimulant affecting dopamine transporter (dat) activity and leading to continuous excess extracellular dopamine levels. |
2023-02-03 |
2023-08-14 |
mouse |
| Haejun Lee, Young Hee Sung, Kyung Hoon Hwan. Additional Role of Midbrain F-18 FP-CIT Uptake on PET in Evaluation of Essential Tremor and Parkinsonism. Current medical imaging. 2023-02-03. PMID:36734891. |
fluorine-18 n-(3-fluoropropyl)-2βcarboxymethoxy-3β-(4-iodophenyl) nortropane (f-18 fp-cit) has been used in the evaluation of parkinsonism by its uptake in the dopamine active transporter (dat) of the striatum. |
2023-02-03 |
2023-08-14 |
Not clear |
| Marco Niello, Spyridon Sideromenos, Ralph Gradisch, Ronan O Shea, Jakob Schwazer, Julian Maier, Nina Kastner, Walter Sandtner, Kathrin Jäntsch, Carl R Lupica, Alexander F Hoffman, Gert Lubec, Claus J Loland, Thomas Stockner, Daniela D Pollak, Michael H Baumann, Harald H Sitt. Persistent binding at dopamine transporters determines sustained psychostimulant effects. Proceedings of the National Academy of Sciences of the United States of America. vol 120. issue 6. 2023-02-02. PMID:36730201. |
psychostimulants interacting with the dopamine transporter (dat) can be used illicitly or for the treatment of specific neuropsychiatric disorders. |
2023-02-02 |
2023-08-14 |
mouse |
| Dieter Kunz, Sophia Stotz, Jan de Zeeuw, Alexandra Papakonstantinou, Susanne Dümchen, Martin Haberecht, Michail Plotkin, Frederik Be. Prognostic biomarkers in prodromal α-synucleinopathies: DAT binding and REM sleep without atonia. Journal of neurology, neurosurgery, and psychiatry. 2023-02-01. PMID:36725328. |
the most reliable marker of progression is reduced striatal dopamine transporter (dat) binding, but low availability of imaging facilities limits general use. |
2023-02-01 |
2023-08-14 |
Not clear |
| Adithya Gopinath, Tabish Riaz, Emily Miller, Leah Phan, Aidan Smith, Ohee Syed, Stephen Franks, Luis R Martinez, Habibeh Khoshboue. Methamphetamine induces a low dopamine transporter expressing immunophenotype without altering total number of peripheral immune cells. Basic & clinical pharmacology & toxicology. 2023-01-29. PMID:36710070. |
methamphetamine is a widely abused psychostimulant and one of the main targets of dopamine transporter (dat). |
2023-01-29 |
2023-08-14 |
mouse |
| Adithya Gopinath, Phillip M Mackie, Leah T Phan, Rosa Mirabel, Aidan R Smith, Emily Miller, Stephen Franks, Ohee Syed, Tabish Riaz, Brian K Law, Nikhil Urs, Habibeh Khoshboue. Who Knew? Dopamine Transporter Activity Is Critical in Innate and Adaptive Immune Responses. Cells. vol 12. issue 2. 2023-01-21. PMID:36672204. |
the dopamine transporter (dat) regulates the dimension and duration of dopamine transmission. |
2023-01-21 |
2023-08-14 |
mouse |
| Michael R Chojnacki, Eric B Thorndike, John S Partilla, Kenner C Rice, Charles W Schindler, Michael H Bauman. The Journal of pharmacology and experimental therapeutics. 2023-01-20. PMID:36669877. |
synaptosomes were prepared from rat caudate for dopamine transporter (dat) assays, or from whole brain minus caudate and cerebellum for norepinephrine transporter (net) and serotonin transporter (sert) assays. |
2023-01-20 |
2023-08-14 |
rat |
| Daniel Kalinowski, Krystyna Bogus-Nowakowska, Anna Kozłowska, Maciej Równia. Dopaminergic and cholinergic modulation of the amygdala is altered in female mice with oestrogen receptor β deprivation. Scientific reports. vol 13. issue 1. 2023-01-17. PMID:36650256. |
the results show that among dopaminergic markers, the expression of tyrosine hydroxylase (th), dopamine transporter (dat) and dopamine d |
2023-01-17 |
2023-08-14 |
mouse |
| Patrick J Kearney, Nicholas C Bolden, Elizabeth Kahuno, Tucker L Conklin, Gilles E Martin, Gert Lubec, Haley E Melikia. Presynaptic Gq-coupled receptors drive biphasic dopamine transporter trafficking that modulates dopamine clearance and motor function. The Journal of biological chemistry. 2023-01-14. PMID:36640864. |
extracellular dopamine (da) levels are constrained by the presynaptic da transporter (dat), a major psychostimulant target. |
2023-01-14 |
2023-08-14 |
Not clear |
| Riccardo Camedda, Chiara Giuseppina Bonomi, Martina Gaia Di Donna, Agostino Chiaravallot. Functional Correlates of Striatal Dopamine Transporter Cerebrospinal Fluid Levels in Alzheimer's Disease: A Preliminary International journal of molecular sciences. vol 24. issue 1. 2023-01-08. PMID:36614193. |
functional correlates of striatal dopamine transporter cerebrospinal fluid levels in alzheimer's disease: a preliminary the aim of our study was to investigate regional glucose metabolism with 18f-fdg positron emission tomography/computed tomography in a population of patients with alzheimer's disease (ad) in relation to cerebrospinal (csf) levels of striatal dopamine transporter (dat). |
2023-01-08 |
2023-08-14 |
Not clear |
| Ji Hwan Kim, Jonghu Jeon, Young Lee, Seung Min Kim, Miju Cheon, Jun Yup Ki. Striatal Dopaminergic Loss and Dysphagia in Parkinson Disease. Clinical nuclear medicine. vol 48. issue 2. 2023-01-06. PMID:36607363. |
to better understand the development of dysphagia in patients with parkinson disease (pd) and to identify possible neuromodulatory target regions of dysphagia, we studied the striatal dopamine transporter (dat) availability distribution by subtype of dysphagia. |
2023-01-06 |
2023-08-14 |
Not clear |